Vaccitech plc
VACC · NASDAQ
12/31/2024 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.15 | 0.43 | 0.06 |
| FCF Yield | -24.07% | -23.50% | -11.72% | -10.16% |
| EV / EBITDA | 21.51 | -18.89 | -1.79 | -6.94 |
| Quality | ||||
| ROIC | 0.80% | -1.34% | -16.72% | -46.39% |
| Gross Margin | 0.00% | 5.26% | -7,501.12% | -198.47% |
| Cash Conversion Ratio | 0.47 | -2.71 | 0.64 | 0.61 |
| Growth | ||||
| Revenue 3-Year CAGR | 282.25% | 110.10% | -66.04% | 1,689,134.97% |
| Free Cash Flow Growth | 0.00% | 39.02% | -197.93% | 39.81% |
| Safety | ||||
| Net Debt / EBITDA | -83.89 | -35.75 | 4.57 | -0.19 |
| Interest Coverage | -22.19 | -181.79 | -16.95 | -5.57 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -29.67 | -16.10 | 125.91 |